Risks

Five things for pharma marketers to know: Tuesday, August 8, 2017

Five things for pharma marketers to know: Tuesday, August 8, 2017

By

A shorter list of risks in TV ads helps consumer comprehension; medical-school choice affects prescribing patterns; reps often show docs the same info

Five things for pharma marketers to know: Wednesday, July 26, 2017

Five things for pharma marketers to know: Wednesday, July 26, 2017

By

Jury says AbbVie fraudulently misrepresented risks of AndroGel; Celgene settles False Claims Act lawsuit; Amgen reports more Repatha prescribers

Five things for pharma marketers to know: Friday, May 26, 2017

Five things for pharma marketers to know: Friday, May 26, 2017

By

FDA presents ideas to tackle drug prices; patients aware of side effects more likely to report them; scientists use Apple's Research Kit for clinical purposes

The FDA cites risk info in letter over Contrave DTC ad

The FDA cites risk info in letter over Contrave DTC ad

By

The regulator also took issue with how Orexigen Therapeutics presented the risk information